02.11.2024
... -4,35%, Lanxess -6,06%, Epigenomics -6,99%, Stratec Biomedical -9,08 ... % , Paion -5,2% , Lanxess -5,66% , Epigenomics -8,58% , Biogen Idec -8,92% , Merck ...
26.10.2024
... -4,73%, Merck KGaA -5,1%, Epigenomics -6,99%, Sartorius -8,11%, ... Idec -6,1% , Baxter International -7,72% , Epigenomics -8,58% , Merck Co. -9,55% ...
19.10.2024
... -0,94%, Stratec Biomedical -2,36%, Epigenomics -6,99%, Paion -11,35%, ... -7,41% , Merck Co. -8,11% , Epigenomics -8,58% , Evotec -10,49% , Medigene ...
12.10.2024
... -2,06%, Lanxess -2,34%, Valneva -3,9%, Epigenomics -6,99%, Evotec -8,14%, Paion - ... -6,81% , Merck KGaA -7,84% , Epigenomics -8,58% , Medigene -12,88% , ...
05.10.2024
... -6,47%, Baxter International -6,66%, Epigenomics -6,99%, Paion -11,35%, ... Biotech -7,46% , Roche GS -8,2% , Epigenomics -8,58% , Biogen Idec -9,76% , ...
26.06.2024
... % Verlust von 3,57 auf 3,11), Epigenomics 3 Tage im Minus (5,33% Verlust ...
16.02.2024
... ,89% Verlust von 4,5 auf 0,01), Epigenomics 3 Tage im Minus (5,33% Verlust ...
26.10.2023
... % Verlust von 3,16 auf 3,13), Epigenomics 3 Tage im Minus (5,33% Verlust ...
11.10.2023
... im 2. Quartal 2023/24 ECX1 Epigenomics: Vollzug über die Veräußerung nahezu ...
28.03.2023
... , Porsche, Neste, Siemens Energy, Coinbase, Epigenomics, Paion, Accento Real Estate, Delivery ...